Lila Sciences Stock

About Lila Sciences

Lila Sciences is an AI-for-science company building what it calls scientific superintelligence, an AI system meant to run the full scientific method on its own. Its scientific reasoning model, Lila Iris, generates hypotheses, designs experiments and interprets results, and its AI Science Factories are robotic labs that physically run those experiments and feed the data back into the model. The platform is aimed at drug discovery, chemicals, advanced materials, energy and defense, and the company points to novel antibodies, green hydrogen catalysts and carbon capture materials as early results. Lila makes money by selling partners access to that platform, either through Catalyst, which puts Lila Iris and the labs in the hands of a customer's own scientists on a lab-as-a-service basis, or through Creation, where Lila runs an end-to-end discovery campaign and hands back validated molecules, materials and intellectual property. It was founded in the labs of Flagship Pioneering and is led by co-founder and CEO Geoffrey von Maltzahn, the founding CEO of Generate:Biomedicines, Tessera Therapeutics, and Indigo Ag.